Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

NKTRNKTR
5 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in Nektar Therapeutics

TWO SIGMA INVESTMENTS, LP holds 1.2M shares of NKTR (Nektar Therapeutics), worth $83.9M as of 2026-Q2. The position was increased (+29.1% shares). NKTR represents 0.1% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$83.9M

Current Shares

1.2M

Total Value Change

+$81.9M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+29.1%
$83.9M0.1%$69.81
37
2026-Q1
Increased
930,741
+96.8%
$67M0.1%$68.11
47
2025-Q4
Increased
473,014
+8.9%
$20M0.0%$41.90
31
2025-Q3
Increased
434,237
+446.9%
$24.7M0.0%$58.92
46
2025-Q2
New
79,395
-
$2.1M0.0%$25.76
36

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used